SCHEMBL7475048

SCHEMBL7475048

CCC(CC)Nc1nc(C)c(-c2c(OC)cc(CCF)cc2OC)nc1OC

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6202546 0.89 CRHR1 (0.55) CRHR1
SCHEMBL5434392 0.87 CRHR1 (0.57) CRHR1
SCHEMBL5437987 0.86 CRHR1 (0.56) CRHR1
SCHEMBL5533554 0.86 CRHR1 (0.60) CRHR1
SCHEMBL5415379 0.85 CRHR1 (0.60) CRHR1
SCHEMBL6074526 0.84 CRHR1 (0.67) CRHR1
SCHEMBL5441012 0.84 CRHR1 (0.54) CRHR1
SCHEMBL5421186 0.84 CRHR1 (0.59) CRHR1
SCHEMBL5434960 0.83 CRHR1 (0.58) CRHR1
SCHEMBL5434364 0.83 CRHR1 (0.70) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP disclosed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO disclosed